Efficacy and Safety of Ceftaroline Fosamil in Hospitalized Patients with Community-Acquired Pneumonia in China: Subset Analysis of an International Phase 3 Randomized Controlled Trial

BACKGROUND: Ceftaroline fosamil has demonstrated superior clinical efficacy versus ceftriaxone for hospitalized adults with moderate-to-severe community-acquired pneumonia (CAP) in a Phase 3 trial in Asia and in a meta-analysis of three trials in Asia, North America, and Europe. Efficacy and safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuo, Chao, Huang, Yijiang, Liu, Wenyuan, Xu, Jin-Fu, Zhu, Wei Yun, Stone, Gregory G, Yan, Jean Li, Mohamed, Naglaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882473/
https://www.ncbi.nlm.nih.gov/pubmed/35237053
http://dx.doi.org/10.2147/IDR.S342558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882473/
https://www.ncbi.nlm.nih.gov/pubmed/35237053
http://dx.doi.org/10.2147/IDR.S342558

Ejemplares similares